Company Information

  

Address: 4B CEDAR BROOK DRIVE  
City: CRANBURY 
State: NJ 
Zip Code: 08512 
Telephone: 609-495-2200 

Description of Business

Primary SIC Code: 2834
(As filed with the SEC)  

We are a biopharmaceutical company developing targeted, receptor-specific peptide therapeutics for the treatment of diseases with significant unmet medical need and commercial potential. Our programs are based on molecules that modulate the activity of the melanocortin and natriuretic peptide receptor systems. Our lead product in clinical development is bremelanotide for the treatment of premenopausal women with hypoactive sexual desire disorder ("HSDD"), which is a type of female sexual dysfunction ("FSD"), defined as low desire with associated distress. In addition, we have drug candidates and development programs for cardiovascular diseases and inflammatory diseases. The following drug development programs are actively under development: ? Bremelanotide, an as-needed subcutaneous injectable product for the treatment of HSDD in premenopausal women.  ... More ...  

Per Share Overview

Date 12-mos Rolling EPS Dividend P/E Ratio
09/20170.06NA11.05
06/2017-0.07NAN/E
03/2017-0.23NAN/E
12/2016-0.30NAN/E
09/2016-0.33NAN/E
06/2016-0.33NAN/E
03/2016-0.35NAN/E
12/2015-0.34NAN/E

Key Financial Ratios and Statistics

FYE: 06/30

Profitability 2017 Leverage 2017
Net Inc/Comm Equity-0.04Total Liab/Total Assets1.09
Net Inc/Total Assets-0.23Total Liab/Inv Cap-10.39
Net Inc/Inv Cap2.23Total Liab/Comm Equity0.18
Pretax Inc/Net Sales-0.29Interest Coverage Ratio-4.61
Net Inc/Net Sales-0.30Curr Debt/Equity-1.52
Cash Flow/Net Sales0.29LTD/Equity-1.22
SG&A/NetSales0.21Total Debt/Equity-2.73
Asset Utilization   Liquidity  
Net Receivables Turnover5.92Quick Ratio1.03
Inventory TurnoverNACurrent Ratio1.03
Inventory Day SalesNANet Rec/Curr Assets0.27
Net Sales/Work Cap27.68Inv/Curr AssetsNA
Net Sales/PP&E225.70  

Income Statement (Millions)

  9/30/2017 6/30/2017 3/31/2017 12/31/2016
Total Revenues(Net Sales) 26.94 33.90 10.82 0.00
Cost of Goods Sold NA NA NA NA
Selling & Admin Exps 1.54 2.32 4.77 1.31
Operating Income 11.23 14.32 -3.01 -9.44
Interest Exp 0.46 0.51 0.56 0.59
Pretax Income 10.83 13.82 -3.56 -10.03
Other Income 0.05 0.01 0.01 0.01
Net Income Bef Extraordinary ... NA NA NA NA
Net Income 10.60 13.32 -3.56 -10.03

Balance Sheet (Millions)

Assets 9/30/2017 6/30/2017 3/31/2017 12/31/2016
Cash & Short Term Investments 39.96 40.45 55.43 13.49
Receivables - Total 9.39 15.12 4.66 NA
Inventories - Total NA NA NA NA
Total Current Assets 50.29 56.58 61.15 14.33
Net Property, Plant & Equipment 0.19 0.20 0.07 0.08
Total Assets 50.54 56.83 61.28 14.47
Liabilities        
Accounts Payable 11.42 12.07 9.56 12.15
Debt in Current Liabilities 7.86 7.84 7.81 7.46
Total Current Liabilities 39.44 54.96 71.21 19.61
Long-Term Debt 4.31 6.28 8.25 10.21
Total Liabilities 44.56 62.00 80.14 30.43
Stockholder's Equity        
Minority Interest NA NA NA NA
Preferred Stock 0.00 0.00 0.00 0.00
Common Stock 1.84 1.61 1.45 1.33
Retained Earnings -346.14 -356.74 -370.06 -366.49
Treasury Stock NA NA NA NA
Total Stockholders' Equity 5.98 -5.16 -18.86 -15.96
Total Liabilities and Stockholders' Equity 50.54 56.83 61.28 14.47

Cash Flow Summary (Millions)

Categories 9/30/2017 6/30/2017 3/31/2017 12/31/2016
Net Cash Provided by Operating Activities 1.43 -12.89 43.50 -11.13
Net Cash Provided by Investing Activities -0.01 0.54 0.45 0.00
Net Cash Provided by Financing Activities -1.92 -1.96 -1.56 14.38

Annual Summary Data (Millions)

Year Sales Net Income EPS
06/20130.01-20.86-0.21
06/20140.00-13.93-0.13
06/201512.95-17.67-0.15
06/20160.00-51.71-0.33
06/201744.72-13.33-0.07
Growth Rates710.56----

Stock Ownership

Type Date(Q,M) No. Owners Shares Held (000s) % Own
Institutional09/30/175617,7249.31




Report Date : 12/4/2017

Powered By Edgar Online © 2017EDGAR®Online, a division of Donnelley Financial Solutions. EDGAR® is a federally registered trademark of the U.S. Securities and Exchange Commission. EDGAR Online is not affiliated with or approved by the U.S. Securities and Exchange Commission.